Abstract
THE platelet-activating factor PAF (l-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent lipid first messenger active in general cell activation, fertilization, inflammatory and allergic reactions, asthma, HIV pathogenesis, carcinogenesis, and apoptosis1–5. There is substantial evidence that PAF is involved in intracellular signalling, but the pathways are poorly understood. Inactivation of PAF is carried out by specific intra- and extracellular acetylhydrolases6 (PAF-AHs), a subfamily of phospho-lipases A2 that remove the sn-2 acetyl group. Mammalian brain contains at least three intracellular isoforms, of which PAF-AH(Ib) is the best characterized7–9. This isoform contains a heterodimer of two homologous catalytic subunits α1 and α2,, each of relative molecular mass 26K, and a non-catalytic 45K β-subunit, a homologue of the β-subunit of trimeric G proteins. We now report the crystal structure of the bovine α1 subunit of PAF-AH(Ib) at 1.7 Å resolution in complex with a reaction product, acetate. The tertiary fold of this protein is closely reminiscent of that found in p21ras and other GTPases. The active site is made up of a trypsin-like triad of Ser 47, His 195 and Asp 192. Thus, the intact PAF-AH(Ib) molecule is an unusual G-protein-like (α1/α2)β trimer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Venable, M. E., Zimmerman, G. A., Mclntyre, T. M. & Prescott, S. M. J. Lipid Res. 34, 691–702 (1993).
O'Flaherty, J. T. & Wykle, R. L. in Platelet Activating Factor and Human Disease (eds Barnes, P. J., Page, C. P. & Henson, P.) 117–137 (Blackwell Scientific, Oxford, 1989).
El Azzouzi, B., Jurgens, P., Beneviste, P. & Thomas, Y. Biochem. Biophys. Res. Commun. 190, 320–324 (1993).
Shukla, D. FASEB J. 6, 2296–2301 (1992).
Bennett, S. A., Leite, L. C. & Birnboim, H. C. Carcinogenesis 14, 1289–1296 (1993).
Stafforini, D. M., Prescott, S. M., Zimmerman, G. A. & Mclntyre, T. M. Biochim. Biophys. Acta 1301, 161–173 (1996).
Hattori, M., Adachi, H., Tsujimoto, M., Arai, H. & Inoue, K. J. Biol. Chem. 269, 23150–23155 (1994).
Hattori, M., Adachi, H., Tsujimoto, M., Arai, H. & Inoue, K. Nature 370, 216–218 (1994).
Hattori, M. et al. J. Biol. Chem. 270, 31345–31352 (1995).
Bazan, N. G. & Rodriguez de Turco, E. B. Neurochem. Intern. 26, 435–441 (1995).
Kumar, R., Harvey, S., Kester, N., Hanahan, D. & Olson, M. Biochim. Biophys. Acta 963, 375–383 (1988).
Panetta, T., Marcheselli, V. L., Braquet, P., Spinnewyn, B. & Bazan, N. G. Biochem. Biophys. Res. Commun. 149, 580–587 (1987).
Kato, K., Clark, G. D., Bazan, N. G. & Zorumski, D. F. Nature 367, 175–179 (1994).
Reiner, O. et al. Nature 364, 717–721 (1993).
Derewenda, Z. S. & Wei, Y. J. Am. Chem. Soc. 117, 2104–2105 (1995).
Tjoelker, L. W. et al. J. Biol. Chem. 270, 25481–25487 (1995).
Derewenda, Z. S. Adv. Prot. Chem. 45, 1–52 (1994).
Stremler, K. E., Stafforini, D. M., Prescott, S. M. & Mclntyre, T. M. J. Biol. Chem. 266, 11095–11103 (1991).
Hattori, K. et al. J. Biol. Chem. 270, 22308–22313 (1995).
Sondek, J., Bohm, A., Lambright, D. G., Hamm, H. E. & Sigler, P. B. Nature 379, 369–374 (1996).
Hattori, M., Arai, H. & Innoue, K. J. Biol. Chem. 268, 18748–18753 (1993).
Reiner, O. et al. J. Neurosci. 15, 3730–3738 (1995).
Mizuguchi, M., Takashima, S., Kakita, A., Yamada, M. & Ikeda, K. Am. J. Path. 147, 1142–1151 (1995).
Xiang, X., Osmani, A. H., Osmani, S. A., Xin, M. & Morris, N. R. Mol. Biol. Cell 6, 297–310 (1995).
Wang, D. S. et al. Biochem. Biophys. Res. Commun. 209, 622–629 (1995).
Adachi, H., Tsujimoto, M., Hattori, M., Arai, H. & Inoue, K. Biochem. Biophys. Res. Commun. 214, 180–187 (1995).
Zhang, K. Y. J. Acta Crystallogr. D 49, 213–222 (1993).
Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Acta Crystallogr. A47, 110–119 (1991).
Laskowski, R. A., McArthur, M. W., Moss, D. S. & Thornton, J. M. J. Appl. Crystal. 20, 282–291 (1993).
Nicholls, A., Sharp, K. & Honig, B. Proteins 11, 281–296 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ho, Y., Swenson, L., Derewenda, U. et al. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature 385, 89–93 (1997). https://doi.org/10.1038/385089a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/385089a0
This article is cited by
-
Structural insights into the molecular mechanisms of pectinolytic enzymes
Journal of Proteins and Proteomics (2019)
-
Neuroprotective effects of chronic hesperetin administration in mice
Archives of Pharmacal Research (2008)
-
Human glutaminyl cyclase and bacterial zinc aminopeptidase share a common fold and active site
BMC Biology (2004)
-
Detection and characterization of 45 kDa platelet activating factor acetylhydrolase in cerebrospinal fluid of children with meningitis
Archives of Pharmacal Research (2003)
-
Lipids and retroviruses
Lipids (2000)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.